Search

Bifikafusp alfa

Bifikafusp alfa is under investigation in clinical trial NCT05329792 (L19IL2/L19TNF in Skin Cancer Patients).

(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid

This compound belongs to the benzenes and substituted derivatives. These are aromatic compounds containing at least one benzene ring. This medication targets the protein beta-lactamase.

PZM21

PZM21 is a novel μ-opioid receptor (MOPr) ligand that has been reported to induce minimal arrestin recruitment and be devoid of the respiratory depressant effects characteristic of classical μ-opioid ligands

Maridebart Cafraglutide

Maridebart Cafraglutide is under investigation in clinical trial NCT05669599 (Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity

Ivarimod

The usage of the INN stem '-imod' in the name indicates that Ivarimod is a immunomodulator, both stimulant/suppressive and stimulant. Ivarimod has a monoisotopic molecular weight of 512.33 Da.

Sulamserod

The usage of the INN stem '-serod' in the name indicates that Sulamserod is a serotonin receptor antagonist and partial agonist. Sulamserod has a monoisotopic molecular weight of 445.14 Da.

Susalimod

The usage of the INN stem '-imod' in the name indicates that Susalimod is a immunomodulator, both stimulant/suppressive and stimulant. Susalimod has a monoisotopic molecular weight of 408.08 Da.

Onfekafusp alfa

Onfekafusp alfa is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal Study).

Protiofate

Gestonorone

Gestonorone is often mistaken for gestonorone capproate which has a different chemical structure.